series-a
Stage
1
Investors
About
Kesmalea Therapeutics develops a pipeline of novel therapeutics founded on the ability to transform large heterobifunctional protein degraders into small molecules, offering oral therapeutics that address protein degradation and stabilization in conditions with unmet medical needs.
Explore Kesmalea Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.